Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Soleno Therapeutics Inc. logo

Soleno Therapeutics Inc.

Sector: Healthcare   

Industry: Diagnostics & Research

42.80
 
USD
  
-0.05
  
(-0.12%)
Optionable: Yes  Market Cap: 1,402 M  90-day average vol: 307,324

Previous close: 42.85  Open: 43.44  Bid: 39.5  Ask: 43.75
52 week range    
2.10   
   53.82
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Friday 29th March 2024
38
MarketXLS Rank
40
Value
53
Technical
23
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

SLNO Income Statement

Annual
Invalid dateDec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AccruedPreferredStockDividends3 M4 M
Basic EPS from continuing operations-5.85-5.85-2.87
Basic EPS total-5.85-5.85-2.87
Basic weighted shares outstanding84668.0628392.01 M598519.01 M2 M4 M5 M8 M
Cost of sales-352683.0-2 M
Depreciation-28516.0-67415.0-33328.0-44000.0-19000.0-11000.011000.019000.020000.0
Depreciation unreconciled-28516.0
DepreciationAndAmortization-28516.0-67415.0-33328.0-44000.0-19000.0-11000.011000.019000.020000.0
Diluted EPS total-163.8-25.35-15.15-26.25-5.85-5.85-2.87
Diluted normalized net income/share-2.87
Diluted weighted shares outstanding84704.0507261.0796383.01 M4 M5 M8 M
DilutedDiscontinuousOperations-6.0-1.05
GainOnSaleOfSecurity2 M
GainsLossOnDisposalOfDiscontinuedOperations-5 M-3 M-1 M
GeneralAndAdministrativeExpense3 M6 M6 M7 M7 M7 M9 M11 M10 M
Gross operating profit254789.0-58518.0173000.0
Income before tax-13 M-16 M-7 M-13 M-12 M-31 M-16 M-32 M-25 M
Income taxes-705280.0-511866.0-2 M-456000.0-1000.0-2 M-2 M-527000.0
Interest income1085.0-1 M-160000.0-478000.0
InterestExpenseNonOperating4 M-1000.02000.0
MiscOtherSpecialCharges-4 M-515860.02 M-1 M626000.0-7 M12 M618000.0330000.0
Net income from total operations-13 M-13 M-20 M-15 M-12 M-31 M-25 M-31 M-24 M
NetIncomeCommonStockholders-13 M-16 M-24 M-15 M-12 M-31 M-16 M-32 M-25 M
NetIncomeContinuousOperations-13 M-13 M-20 M-15 M-12 M-31 M-25 M-31 M-24 M
NetIncomeDiscontinuousOperations-5 M-4 M-1 M
NetNonOperatingInterestIncomeExpense-4 M-1 M-160000.0-478000.0-2000.0
NonRecurringOperationExpense7243.0183565.0-13129.0590114.0
Normalized income-35 M-26 M
Operating income-5 M-12 M-17 M-12 M-14 M-23 M-36 M-32 M-24 M
Operating income before depreciation (EBITDA)-5 M-16 M-7 M-12 M-10 M-29 M-14 M-30 M-24 M
OperatingExpense-5 M-12 M-8 M-12 M-14 M-23 M36 M32 M24 M
Other income net4 M515860.0-2 M1 M-3 M7 M-12 M-618000.0-330000.0
OtherGainLossFromDispositionOfDiscontinuedOperations-194000.0
OtherGandA3 M6 M6 M7 M7 M7 M9 M11 M10 M
OtherOperatingExpenses-44864.0-31657.08 M2 M567000.0289000.0-4 M731000.0712000.0
OtherunderPreferredStockDividend3 M4 M
PreferredStockDividends3 M4 M
RentAndLandingFees3 M6 M6 M7 M7 M7 M
Research & development expense2 M5 M2 M3 M7 M16 M23 M21 M15 M
ResearchExpense2 M5 M2 M3 M7 M16 M23 M21 M15 M
Revenue per share-4 M-40813.0-99343.0-2 M-2 M-2 M2 M2 M2 M
SalariesAndWages-345435.0-942369.0-871270.0-1000000.0-1 M-825000.0
Selling Gen & administrative expense3 M8 M6 M7 M7 M7 M9 M11 M10 M
SellingAndMarketingExpense252359.02 M2 M26000.0
SellingExpense252359.02 M2 M26000.0
Special income/charges-7243.0-183565.013129.0-590114.0
Total Income available for interest expense (EBIT)-9 M-16 M-7 M-13 M-12 M-31 M-16 M-32 M-25 M
Total common shares outstanding90254.0205395.0633065.01 M2 M3 M5 M5 M8 M
Total net income-13 M-13 M-20 M-15 M-12 M-31 M-25 M-31 M-24 M
Total ordinary shares32 M32 M32 M32 M32 M32 M32 M32 M32 M
Total revenues607472.01 M173000.0
TotalExpenses-5 M-13 M-8 M-12 M-14 M-23 M36 M32 M24 M
TotalRevenue387555.01 M173000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University